Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay

Journal of Clinical Microbiology

Volumn 43, Issue 12, 2005, Pages 5950-5956

  Jennings, Cheryl ^a   Fiscus, Susan A ^b   Crowe, Suzanne M ^c   Danilovic, Aleksandra D ^a   Morack, Ralph J ^a   Scianna, Salvatore ^a   Cachafeiro, Ada ^b   Brambilla, Donald J ^d   Schupbach, Jorg ^e   Stevens, Wendy ^f   Respess, Richard ^g   Varnier, Oliviero E ^h   Corrigan, Gary E ⁱ   Gronowitz, J Simon ^j   Ussery, Michael A ^k   Bremer, James W ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^d NEW ENGLAND RESEARCH INSTITUTES   (United States)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j UPPSALA UNIVERSITY   (Sweden)

^k NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BUFFER; VIRUS RNA;

ARTICLE; COST; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; REPRODUCIBILITY; RNA ANALYSIS; TECHNOLOGY; VIRUS DETECTION; VIRUS LOAD; VIRUS SPIKE;

HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 30744450025     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.12.5950-5956.2005     Document Type: Article

References (39)

1. Bonard, D., F. Rouet, T. A. Toni, A. Minga, C. Huet, D. K. Ekouevi, F. Dabis, R. Salamon, C. Rouzioux, et al. 2003. Field evaluation of an improved assay using heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Cote d'Ivoire, West Africa. J. Acquir. Immune. Defic. Syndr. 34:267-273.
2. Boni, J., M. Opravil, Z. Tomasik, M. Rothen, L. Bisset, P. J. Grob, R. Luthy, and J. Schupbach. 1997. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS 11:F47-F52.
3. Braun, J., J.-C. Plantier, M.-F. Hellot, E. Tuaillon, M. Gueudin, F. Damond, A. Malmsten, G. E. Corrigan, and F. Simon. 2003. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for different types, groups and subtypes. AIDS 17:331-336.
4. Brown, C., R. Kline, L. Atibu, H. Francis, R. Ryder, and T. C. Quinn. 1991. Prevalence of HIV-1 p24 antigenaemia in African and North American populations and correlation with clinical status. AIDS 5:89-92.
5. Coffin, J. M. 1996. Retroviridae: the viruses and their replication, p. 1767-1847. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
6. Crowe, S., S. Turnbull, R. Oelrichs, and A. Dunne. 2003. Monitoring of human immunodeficiency virus infection in resource-constrained countries. CID 37(Suppl. 1):S25-S35.
7. Erice, A., D. Brambilla, B. Jackson, R. Kokka, B. Yen-Lieberman, and R. Coombs. 2000. Performance characteristics of the Quantiplex HIV-1 RNA 3.0 assay for the detection and quantitation of HIV-1 RNA in plasma. J. Clin. Microbiol. 38:2837-2845.
8. Giacomini, M., J. L. McDermott, A. A. Giri, I. Martini, F. B. Lillo, and O. E. Varnier. 1998. A novel and innovative kinetic software for virologic colorimetric assays. J. Virol. Methods 73:201-209.
9. Greengrass, V. L., S. P. Turnbull, J. Hocking, A. L. Dunne, G. Tachedjian, G. E. Corrigan, and S. M. Crowe. 2005. Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring. Curr. HIV Res. 3:183-190.
10. Hammer, S., C. Crumpacker, R. D'Aquila, B. Jackson, J. Lathey, D. Livnat, and P. I. Reichelderfer. 1993. Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee. J. Clin. Microbiol. 31:2557-2564.
11. Huang, D. D., T. A. Giesler, and J. W. Bremer. Sequence characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel. AIDS Res. Hum. Retrovir. 19:321-328.
12. Kent, D. M., D. McGrath, J. P. A. Ioannidis, and M. L. Bennish. 2003. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda. CID 37(Suppl. 1):S13-S24.
13. Lange, J. M., D. A. Paul, H. G. Huisman, F. de Wolf, H. van den Berg, R. A. Coutinho, S. A. Danner, J. van der Noordaa, and J. Goudsmit. 1986. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. BMJ 293:1459-1462.
14. Ledergerber, B., M. Flepp, J. Boni, Z. Tomasik, R. W. Cone, R. Luthy, and J. Schupbach. 2000. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS and survival: comparison with viral RNA measurement. J. Infect. Dis. 181:1280-1288.
15. Lyamuya, E., U. Bredberg-Raden, A. Massawe, E. Urassa, G. Kawo, G. Msemo, T. Kazimoto, A. Ostborn, K. Karlsson, F. Mhalu, and G. Biberfeld. 1996. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J. Acquir. Immune. Defic. Syndr. Hum. Retrovir. 12:421-426.
16. Malmsten, A., X. W. Shao, K. Aperia, G. E. Corrigan, E. Sandstrom, C. F. Kallander, T. Leitner, and J. S. Gronowitz. 2003. HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J. Med. Virol. 71:347-359.
17. Malmsten, A., X. W. Shao, S. Sjodahl, E. L. Fredriksson, I. Pettersson, T. Leitner, C. F. R. Kallander, E. Sandstrom, and J. S. Gronowitz. 2005. Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J. Med. Virol. 76:291-296.
18. Malmsten, A., D. H. Ekstrand, L. Akerblom, J. S. Gronowitz, C. F. Kallander, M. Bendinelli, and D. Matteucci. 1998. A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity. J. Virol. Methods 75:9-20.
19. Nishanian, P., K. R. Huskins, S. Stehn, R. Detels, and J. L. Fahey. 1990. A simple method for improved assay demonstrates that p24 antigen is present as immune complexes in most sera from infected individuals. J. Infect. Dis. 162:21-28.
20. Pascual, A., A. Cachafeiro, M. L. Funk, and S. A. Fiscus. 2002. Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay. J. Clin. Microbiol. 40:2472-2475.
21. Prado, J. G., A. Shintani, M. Bofill, B. Clotet, L. Ruiz, and J. Martinez-Picado. 2004. Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic HIV infection during structured treatment interruptions. J. Clin. Microbiol. 42:1620-1625.
22. Respess, R. A., A. Cachafeiro, D. Withum, S. A. Fiscus, D. Newman, B. Branson, O. E. Varnier, K. Lewis, and T. J. Dondero. 2005. Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings. J. Clin. Microbiol. 43:506-508.
23. Ribas, S. G., P. Ondoa, J. Schupbach, G. van der Groen, and K. Fransen. 2003. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1-seropositive individuals. J. Virol. Methods 113:29-34.
24. Schupbach, J., and J. Boni. 1993. Quantitative and sensitive detection of immune-complexed and free HIV antigen after boiling of serum. J. Virol. Methods 43:247-256. (Erratum, 45:245.)
25. Schupbach, J. 2003. Viral RNA and p24 antigen as markers of HIV disease and antiretroviral treatment success. Int. Arch. Allergy Immunol. 132:196-209.
26. Schupbach, J., J. Boni, L. R. Bisset, Z. Tomasik, M. Fischer, H. F. Gunthard, B. Ledergerber, M. Opravil, et al. 2003. HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 33:292-299.
27. Schupbach, J. 2002. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and in expensive alternative to tests for viral RNA. AIDS Rev. 4:83-92.
28. Schupbach, J., Z. Tomasik, D. Nadal, B. Ledergerber, M. Flepp, M. Opravil, and J. Boni. 2000. Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. Int. J. Antimicrob. Agents 16:441-445.
29. Schupbach, J., J. Boni, M. Flepp, Z. Tomasik, H. Joller, and M. Opravil. 2001. Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an in expensive alternative to tests for viral RNA. J. Med. Virol. 65:225-232.
30. Schupbach, J., J. Boni, L. R. Bisset, Z. Tomasik, M. Fischer, H. F. Gunthard, B. Ledergerber, M. Opravil, et al. 2003. HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 33:292-299.
31. + loss. J. Acquir. Immune. Defic. Syndr. 40:250-256.
32. Shao, X. W., A. Malmsten, J. Lennerstrand, A. Sonnerborg, T. Unge, J. S. Gronowitz, and C. F. R. Kallander. 2003. Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testing. AIDS. 17:1463-1471.
33. Sherman, G. G., G. Stevens, and W. S. Stevens. 2004. Affordable diagnosis of human immunodeficiency virus infection in infants by p24 antigen detection. Pediatr. Infect. Dis. J. 23:173-176.
34. Sivapalasingam, S. S. Essajee, P. N. Nyambi, V. Itri, B. Hanna, R. Holzman, and F. Valentine. 2005. Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings. J. Clin. Microbiol. 43:3793-3796.
35. Sterling, T. R., D. R. Hoover, J. Astemborski, D. Vlahov, J. G. Bartlett, and J. Schupbach. 2002. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. J. Infect. Dis. 186:1181-1185.
36. Stevens, G., N. Rekhviashvili, L. E. Scott, R. Gonin, and W. Stevens. 2005. Evaluation of two commercially available, inexpensive alternative HIV-1 viral load assays in HIV-infected subtype C patients from South Africa: the HiSen HIV-1 p24 antigen Ultra kit and the Cavidi ExaVir load HIV-RT assay. J. Clin. Microbiol. 43:857-861.
37. Sutthent, R., N. Gaudart, K. Chokpaibulkit, N. Tanliang, C. Kanoksinsombath, and P. Chaisilwatana. 2003. P24 antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 41:1016-1022.
38. Tuaillion, E., M. Gueudin, V. Lemee, I. Gueit, P. Roques, G. E. Corrigan, J.-C. Plantier, F. Simon, and J. Braun. 2004. Phenotypic susceptibility to nonnucleoside inhibitors of virion-associated reverse transcriptase from different HIV types and groups. J. Acquir. Immune Defic. Syndr. 37:1543-1549.
39. Yen-Lieberman, B., D. Brambilla, B. Jackson, J. Bremer, R. Coombs, M. Cronin, S. Herman, D. Katzenstein, S. Leung, H. J. Lin, P. Palumbo, S. Rasheed, J. Todd, M. Vahey, and P. Reichelderfer. 1996. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J. Clin. Microbiol. 34:2695-2701.